FI952953L - Medel för behandling av metaboliska benstommesjukdomar - Google Patents
Medel för behandling av metaboliska benstommesjukdomar Download PDFInfo
- Publication number
- FI952953L FI952953L FI952953A FI952953A FI952953L FI 952953 L FI952953 L FI 952953L FI 952953 A FI952953 A FI 952953A FI 952953 A FI952953 A FI 952953A FI 952953 L FI952953 L FI 952953L
- Authority
- FI
- Finland
- Prior art keywords
- agents
- treatment
- bone diseases
- metabolic bone
- metabolic
- Prior art date
Links
- 208000029725 Metabolic bone disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6135275A JPH083058A (ja) | 1994-06-17 | 1994-06-17 | 新規な骨代謝疾患治療剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI952953A0 FI952953A0 (sv) | 1995-06-15 |
FI952953L true FI952953L (sv) | 1995-12-18 |
Family
ID=15147903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI952953A FI952953L (sv) | 1994-06-17 | 1995-06-15 | Medel för behandling av metaboliska benstommesjukdomar |
Country Status (10)
Country | Link |
---|---|
US (1) | US5726148A (sv) |
EP (1) | EP0687470A3 (sv) |
JP (1) | JPH083058A (sv) |
KR (1) | KR960000248A (sv) |
AU (1) | AU697136B2 (sv) |
CA (1) | CA2152023A1 (sv) |
FI (1) | FI952953L (sv) |
HU (1) | HU218947B (sv) |
NO (1) | NO952411L (sv) |
TW (1) | TW496740B (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020028798A1 (en) * | 1995-12-12 | 2002-03-07 | Omeros Medical Systems | Irrigation solution and method for inhibition of pain and inflammation |
US7091181B2 (en) | 1994-12-12 | 2006-08-15 | Omeros Corporation | Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors |
US7029861B1 (en) | 1998-09-15 | 2006-04-18 | Board Of Regents, The University Of Texas System | LPS-response gene compositions and methods |
JP3755564B2 (ja) | 1999-05-24 | 2006-03-15 | 株式会社村田製作所 | 圧電共振部品及びその製造方法 |
RU2271825C2 (ru) | 1999-07-21 | 2006-03-20 | Омерос Корпорейшн | Растворы и способы ингибирования боли, воспаления и разрушения хряща |
US20050074434A1 (en) * | 2001-02-23 | 2005-04-07 | Tomoaki Hoshino | Remedies for metabolic bone diseases |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989004838A1 (en) * | 1987-11-25 | 1989-06-01 | Immunex Corporation | Interleukin-1 receptors |
US4968607A (en) * | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
US5319071A (en) * | 1987-11-25 | 1994-06-07 | Immunex Corporation | Soluble interleukin-1 receptors |
WO1991000742A1 (en) * | 1989-07-07 | 1991-01-24 | E.I. Du Pont De Nemours And Company | Soluble human b-cell interleukin-1 receptor |
EP0474141B1 (en) * | 1990-09-03 | 1996-01-31 | Kuraray Co., Ltd. | Peptide or its salts |
EP0563239A4 (en) * | 1990-12-20 | 1994-10-12 | Univ Pittsburgh | A truncated interleukin-1 receptor gene for the treatment of arthritis. |
-
1994
- 1994-06-17 JP JP6135275A patent/JPH083058A/ja active Pending
-
1995
- 1995-05-22 TW TW084105068A patent/TW496740B/zh active
- 1995-06-07 US US08/487,646 patent/US5726148A/en not_active Expired - Fee Related
- 1995-06-12 EP EP95109011A patent/EP0687470A3/en not_active Ceased
- 1995-06-15 AU AU21716/95A patent/AU697136B2/en not_active Ceased
- 1995-06-15 FI FI952953A patent/FI952953L/sv unknown
- 1995-06-16 KR KR1019950015948A patent/KR960000248A/ko active IP Right Grant
- 1995-06-16 NO NO952411A patent/NO952411L/no not_active Application Discontinuation
- 1995-06-16 CA CA002152023A patent/CA2152023A1/en not_active Abandoned
- 1995-06-16 HU HU9501779A patent/HU218947B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR960000248A (ko) | 1996-01-25 |
NO952411L (no) | 1995-12-18 |
HU218947B (hu) | 2001-01-29 |
US5726148A (en) | 1998-03-10 |
NO952411D0 (no) | 1995-06-16 |
HUT72054A (en) | 1996-03-28 |
EP0687470A3 (en) | 1996-06-19 |
TW496740B (en) | 2002-08-01 |
AU2171695A (en) | 1996-01-04 |
AU697136B2 (en) | 1998-09-24 |
JPH083058A (ja) | 1996-01-09 |
HU9501779D0 (en) | 1995-08-28 |
CA2152023A1 (en) | 1995-12-18 |
EP0687470A2 (en) | 1995-12-20 |
FI952953A0 (sv) | 1995-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018020I2 (el) | Θεραπεια της νοσου ρομρε | |
FI952721L (sv) | Medel för behandling av lever-gall-sjukdomar | |
DE69522448D1 (de) | Gewebebehandlungskassette | |
FI963696L (sv) | Gel för hudsjukdomsterapi och desinfektering av hud | |
DE69524138D1 (de) | Hautbehandlungsmittel | |
DE69509544D1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
EE03512B1 (et) | Epinastiin kasutamiseks valude ravis | |
EE9900469A (et) | Sulfoonamiidid endoteliini vahendatud haiguste raviks | |
FI970682L (sv) | Anatomiskt utformad kombinerad sanitetsbinda | |
EE200300214A (et) | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks | |
NO20001869D0 (no) | Fremgangsmõte for behandling av Alzheimerssykdom | |
DE69620691D1 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
IL129144A0 (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases | |
FI971527L (sv) | Användning av indolderivat för behandling av olika sjukdomar | |
ID23528A (id) | Pengobatan terapeutik untuk gangguan kulit | |
FI952953L (sv) | Medel för behandling av metaboliska benstommesjukdomar | |
EE03437B1 (et) | Benseenamiidid neurodegeneratiivsete haiguste ravimiseks | |
NO982562D0 (no) | Sammensetning for behandling av smerte | |
NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
DE69636790D1 (de) | Interferon-beta gegen knochenerkrankungen | |
FI963263A0 (sv) | Medicinsk användning av bromelain | |
ID24922A (id) | Terapi kombinasi untuk pengobatan aids | |
DE69000791D1 (de) | Therapeutische mittel fuer metabolische knochenkrankheiten. | |
EP0755262A4 (en) | PNEUMOPATHY TREATMENT COMPOSITION | |
DE69813354D1 (de) | Mittel zur Behandlung von Herzkrankheiten |